menu
    • menu
    [{"orgOrder":0,"company":"Pascal Biosciences","sponsor":"Sorse Technology","pharmaFlowCategory":"D","therapeuticArea":"Oncology","country":"U.S.A","productType":"Undisclosed","year":"2020","type":"Collaboration","leadProduct":"PAS-393","moa":"Undisclosed","graph1":"Oncology","graph2":"Phase I","graph3":"Pascal Biosciences","amount2":0,"highestDevelopmentShortName":"Ph I","therapeuticAreaShortName":"Oncology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Pascal Biosciences \/ Sorse Technology","highestDevelopmentStatusID":"6","companyTruncated":"Pascal Biosciences \/ Sorse Technology"}]

    Find Oncology Clinical Drug Pipeline Developments & Deals by Pascal Biosciences

    Xls
    Filters Filter
    ×
    FILTER:
    filter
    Company Name
      filter

      Year

        filter

        DEALS // DEV.

          filter

          Country

            filter
            Sponsor
              filter

              Therapeutic Area

                filter

                Study Phase

                  filter

                  Deal Type

                    filter

                    Product Type

                      filter

                      Dosage Form

                        filter

                        Lead Product

                          filter

                          Target

                            Loading...
                            refresh Filters
                            refresh Reset Filter
                            refresh Reset Filter
                            price-trend All Developments

                            Therapeutic Area by Lead Product

                            Study Phase by Lead Product

                            Company by Lead Product

                            Top Deals by Deal Size (USD bn)

                            01

                            Pascal Biosciences

                            U.S.A arrow
                            AAPS National Biotech
                            Not Confirmed

                            Pascal Biosciences

                            U.S.A arrow
                            AAPS National Biotech
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : PAS-393

                            Therapeutic Area : Oncology

                            Study Phase : Phase I

                            Sponsor : Sorse Technology

                            Deal Size : $0.7 million

                            Deal Type : Collaboration

                            DEALS_DEV arrow-down

                            Biotech Company Pascal Biosciences and SORSE Technology Announce Partnership for Cannabinoid Drug Development ...

                            Details : Pascal and SōRSE will share their respective technologies to test the cannabinoid PAS-393 in human volunteers, enabling testing of cancer patients treated with checkpoint inhibitors.

                            Product Name : PAS-393

                            Product Type : Undisclosed

                            Upfront Cash : Undisclosed

                            September 14, 2020

                            Lead Product(s) : PAS-393

                            Therapeutic Area : Oncology

                            Highest Development Status : Phase I

                            Sponsor : Sorse Technology

                            Deal Size : $0.7 million

                            Deal Type : Collaboration

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth